Here are eight things to know:
1. Orthopedics sales dropped 0.7 percent in the first quarter, hitting $2.3 billion. U.S. sales were $1.2 billion, a nearly 1 percent decline, while international sales were only down 0.3 percent to $948 million.
2. The company’s hip sales hit $352 million in the first quarter, up 2.9 percent over the same period last year. The U.S. sales were up 3 percent to $209 million; international hip sales were $143 million.
3. Knee sales in the U.S. were up 0.8 percent to $246 million, and there was a 4.8 percent growth in international knee sales, which hit $152 million. Overall, knee sales were up 2.3 percent to $398 million.
4. Spine sales dropped 3.6 percent to $933 million in the first quarter, driven by a 5.5 percent decline in U.S. spine sales. International spine sales dropped 1 percent.
5. Trauma sales were flat at $642 million in the first quarter. The company reported 2.6 percent growth in U.S. sales, which was offset by a 3.8 percent decrease in international trauma sales.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
